Bone Health versus Fosamax, Boniva…

June 23, 2012 by  
Filed under Osteoporosis

 

             With the approval of Fosamax in 1995, there was basically one remedy for osteoporosis that most medical practitioners considered when addressing osteoporosis. When I was first diagnosed with osteoporosis in 2004, the medical industry was still advocating bisphosphonates (Fosamax, Boniva…) even for pre-menopausal women.  Fosamax enjoyed top billing as the remedy for osteoporosis despite that clinical studies did not show that taking Fosamax reduced fracture rates.

In time, with the plethora of adverse side effects being exposed, more and more doctors began only recommending Fosamax and it’s “cousins” for post-menopausal women.  But still, very few people in the medical field were acknowledging that there was more to osteoporotic fractures than low bone density, and most didn’t consider that people had natural options for strengthening their bones.

As a research biochemist, I have had the opportunity to manipulate systems and evaluate the outcomes. Knowing how our bodies function on the cellular level and how cells respire, I combed the research and clinical studies that claimed to effect bone formation and the activation of osteoblasts (bone forming cells). From these studies, I knew that natural options for increasing bone health had the more promising potential for yielding stronger, healthier bones. This is supported by impressive research.